Background The oral cavity is the most important link between the human body and the external environment and is well-equipped to protect the body against invading pathogens. Emerging data on the bidirectional relationship between oral health and the severity of COVID-19 symptoms has prompted us to reexamine our role as the guardians of the oral cavity - the true gateway to the body. Recent studies have shown that the oral microbiome is a complex ecological system and the interactions between its residents and the host cells influence human health and disease. This narrative review elaborates on the oral-systemic connection from an oral microbiome standpoint and discusses the future role of oral health professionals.Methods A PubMed literature search using the keywords “Oral Microbiome and Diseases” and “Oral microbiome and Health” for a range of ten years between 2012-2022 was completed. Meta-Analyses, Reviews, Randomized Control Trials, Clinical Trials, and books were included in the search.Results “Oral microbiome and Diseases” yielded 6392 results and “Oral microbiome and Health” yielded 4287 results.Conclusion Oral health professionals need to be trained on the oral-systemic connection periodically to appreciate the recent advances in this field.Practical Implications A deeper understanding of the impact of existing treatment modalities on the oral microbiome could expand the role of oral health professionals in preventing and maintaining patients' overall health. Implementing point-of-care salivary diagnostics to detect salivary biomarkers for oral and non-oral diseases and conditions may be a significant leap toward this goal. 

Oral Cavity is the Gateway to the Body: Role of Oral Health Professionals: A Narrative Review

Introduction Breast cancer is the world's most prevalent malignancy, with an increasing incidence and a predisposition for postpubertal females from all cultural and ethnic backgrounds. More recently, oral Fusobacterium nucleatum species have been observed in cancerous human breast tissue, drawing attention to the role of microbes in cancer pathogenesis. Objectives Investigating oral Fusobacterium nucleatum species as potential biomarkers for female-specific breast cancer. Methods A systematic search in The Central Register of Controlled Trials, EMBASE, EBSCO, NCBI, and MEDLINE databases was undertaken from the 1st January, 1983–31st March, 2022. Articles included were in English and based on women between the ages of 18–96 years with confirmed gingivitis/periodontal disease and breast cancer diagnoses from registered specialists. Authors extracted data independently, and a meta-analysis of risk estimations measuring associations between oral Fusobacterium nucleatum species and female-specific breast cancer was elucidated via calculated relative risks and 95% confidence intervals. Results AXIS tool analysis revealed 78.70% of articles with a positive correlation between oral Fusobacterium nucleatum and female-specific breast cancer. The risk of breast cancer development increased with significant levels of oral Fusobacterium nucleatum due to gingivitis/periodontitis (relative risk = 1.78, 95% confidence interval = 1.63–1.91). Low-moderate statistical heterogeneity was found (I2 = 41.39%; P = 0.02), and the importance of periodontal status on breast cancer pathogenesis was determined (relative risk = 1.24, 95% confidence interval = 1.01–1.30). Conclusions Oral Fusobacterium nucleatum species are a risk factor for breast cancer development, thus elevating their biomarker potentiality.

/pdf/the-role-of-oral-fusobacterium-nucleatum-in-female-breast-1knaxwpe.pdf

Raquel González Martïnez

Papers

The Role of Oral Fusobacterium nucleatum in Female Breast Cancer: A Systematic Review and Meta-Analysis